Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Fallopian Tube Cancer|Female Reproductive Cancer|Recurrent Breast Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Breast Cancer|Stage IV Ovarian Epithelial Cancer
Interventions: DRUG: ixabepilone|DRUG: pegylated liposomal doxorubicin hydrochloride
Sponsor: National Cancer Institute (NCI)